It has been recognized that it can inhibit tumor proliferation by regulating several target genes [28], for example, miR-101 can directly inhibit cell proliferation by reducing the expression of zeste homolog 2 (EZH2) enhancer in lung cancer and embryonic rhabdomyosarcoma (eRMS) [29]. Here, EZH2 is linked to embryonal rhabdomyosarcoma.